{"id":44799,"date":"2025-10-28T13:36:59","date_gmt":"2025-10-28T05:36:59","guid":{"rendered":"https:\/\/flcube.com\/?p=44799"},"modified":"2025-10-28T13:36:59","modified_gmt":"2025-10-28T05:36:59","slug":"nmpa-releases-draft-measures-on-drug-quality-sampling-seeks-public-comments-by-nov-5","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=44799","title":{"rendered":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5"},"content":{"rendered":"\n<p>The National Medical Products Administration (NMPA) today issued the <strong>\u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d<\/strong> and is inviting public feedback until <strong>November\u202f5,\u202f2025<\/strong>. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-scope-of-the-draft-measures\"><strong>Scope of the Draft Measures<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Provincial Responsibility<\/strong> \u2013 Provincial drug regulatory departments will organize and implement sampling and inspection in their jurisdictions, covering:<\/li>\n\n\n\n<li>Production links (finished\u2011product warehouses, raw\u2011material and packaging\u2011material warehouses)<\/li>\n\n\n\n<li>Distribution links (wholesale warehouses, retail chain headquarters, third\u2011party online platforms)<\/li>\n\n\n\n<li>Usage links (retail drug storerooms).<\/li>\n\n\n\n<li><strong>City\u2011County Level Work<\/strong> \u2013 District\u2011city and county\u2011level drug regulatory departments will conduct inspections at retail and use links and carry out tasks delegated by higher authorities.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-sampling-methodology\"><strong>Sampling Methodology<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Link<\/th><th>Typical Sampling Locations<\/th><th>Key Rules<\/th><\/tr><\/thead><tbody><tr><td><strong>Production<\/strong><\/td><td>Finished\u2011product warehouse; raw\u2011material &amp; excipient warehouses<\/td><td>Sample only drugs released into the warehouse and pending sale; exclude \u201cpending inspection,\u201d \u201cnon\u2011conforming,\u201d or \u201creturned\u201d products.<\/td><\/tr><tr><td><strong>Distribution<\/strong><\/td><td>Enterprise drug warehouse; retail premises<\/td><td>Same rules as production.<\/td><\/tr><tr><td><strong>Usage<\/strong><\/td><td>Drug storeroom<\/td><td>Same rules as above.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-online-sampling-protocol\"><strong>Online Sampling Protocol<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Purchase Without Disclosure<\/strong> \u2013 The sampling unit or individual must not reveal the sampling purpose to the online seller.<\/li>\n\n\n\n<li><strong>Prescription Drugs<\/strong> \u2013 May request a medical institution to issue a prescription for the purchase.<\/li>\n\n\n\n<li><strong>Verification<\/strong> \u2013 Prior to sampling, verify the seller\u2019s qualifications and compliance on the platform.<\/li>\n\n\n\n<li><strong>Evidence Capture<\/strong> \u2013 Preserve screenshots, photos, or videos of the product listing, platform interface, and transaction records.<\/li>\n\n\n\n<li><strong>Sample Handling<\/strong> \u2013 Store samples under conditions that maintain integrity for laboratory analysis.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug&#8230;<\/p>\n","protected":false},"author":1,"featured_media":44801,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[14],"class_list":["post-44799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5 - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=44799\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5\" \/>\n<meta property=\"og:description\" content=\"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=44799\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T05:36:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5\",\"datePublished\":\"2025-10-28T05:36:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799\"},\"wordCount\":297,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2804.webp\",\"keywords\":[\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44799#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=44799\",\"name\":\"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5 - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2804.webp\",\"datePublished\":\"2025-10-28T05:36:59+00:00\",\"description\":\"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44799\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2804.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2804.webp\",\"width\":1080,\"height\":608,\"caption\":\"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44799#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5 - Insight, China&#039;s Pharmaceutical Industry","description":"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=44799","og_locale":"en_US","og_type":"article","og_title":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5","og_description":"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.","og_url":"https:\/\/flcube.com\/?p=44799","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-28T05:36:59+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=44799#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=44799"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5","datePublished":"2025-10-28T05:36:59+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=44799"},"wordCount":297,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=44799#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","keywords":["NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=44799#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=44799","url":"https:\/\/flcube.com\/?p=44799","name":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5 - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=44799#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=44799#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","datePublished":"2025-10-28T05:36:59+00:00","description":"The National Medical Products Administration (NMPA) today issued the \u201cMeasures for the Administration of Drug Quality Sampling and Inspection (Draft for Comment)\u201d and is inviting public feedback until November\u202f5,\u202f2025. The draft outlines a comprehensive, multi\u2011tiered framework for sampling and inspection across the entire drug supply chain\u2014from production to retail, including online sales platforms.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=44799#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=44799"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=44799#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","width":1080,"height":608,"caption":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=44799#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov\u202f5"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2804.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=44799"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44799\/revisions"}],"predecessor-version":[{"id":44802,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44799\/revisions\/44802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/44801"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=44799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=44799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=44799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}